Elizabeth Masson-Hurlburt
Net worth: 2 M $ as of 31/05/2026
Net worth: 2 M $ as of 31/05/2026
Elizabeth Masson-Hurlburt is currently EVP, Chief Operating & Integration Officer at CorMedix, Inc., a position starting in 2025.
Formerly, Ms. Masson-Hurlburt was Vice President-Clinical Operations at Gemphire Therapeutics, Inc. from 2016 to 2018.
Education includes undergraduate studies at Bay Path College and graduate studies at Western Governors University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
CORMEDIX INC. 0.36% | 04/02/2026 | 278,539 ( 0.36% ) | 2 M $ | 31/05/2026 |
| Companies | Position | Start |
|---|---|---|
| CORMEDIX INC. | Chief Operating Officer | - |
| Companies | Position | End |
|---|---|---|
| METAVIA INC. | Chief Tech/Sci/R&D Officer | 01/03/2018 |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 4 |
|---|---|
CorMedix, Inc.
CorMedix, Inc. BiotechnologyHealth Technology Develops medical devices for cardiovascular and kidney diseases | Health Technology |
Bay Path College
Bay Path College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western Governors University
Western Governors University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gemphire Therapeutics, Inc.
Gemphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapies for the treatment of Dyslipidemia | Health Technology |
Select your edition
All financial news and data tailored to specific country editions